# Hexagon Bio

Fungal-genomics-driven oncology and infectious-disease drug discovery company

Company Leadership Board of Directors Clinical Advisory Board Scientific Advisory Board Technical Advisory Board Investors Partners Pipeline Technology Overview Antibody-Drug Conjugate (ADC) Platform Publications News Press Releases In the News Careers Open Positions Novel ADC Pa

Canonical: https://uniquebase.ai/companies/hexagon-bio
Stable identifier: UB-C11503
Snapshot captured: 2026-11-01T00:40:31.077Z
English updated: 2026-11-01T02:29:42.392Z

## Funding

Listed 1 record.
Latest: $62 (Series C), 2026-10-23.

- 2026-10-23 · $62 · Series C · The Column Group · https://www.globenewswire.com/news-release/2026/10/23/3387153/0/en/hexagon-bio-raises-62-million-series-c-financing-to-advance-hex-360-into-the-clinic-and-expand-pipeline-of-antibody-drug-conjugates-with-novel-payload-mechanisms.html
  > On 2026-10-23, according to fireround, Hexagon Bio raises $62 million in Series C funding. (translated source brief)

## Valuation

Listed 1 record.

- 2026-10-23 · amount unavailable · Series C · The Column Group · https://www.globenewswire.com/news-release/2026/10/23/3387153/0/en/hexagon-bio-raises-62-million-series-c-financing-to-advance-hex-360-into-the-clinic-and-expand-pipeline-of-antibody-drug-conjugates-with-novel-payload-mechanisms.html
  > On 2026-10-23, according to fireround, Hexagon Bio raises $62 million in Series C funding. (translated source brief)

## Revenue

No revenue records are listed yet.


## Team

No published team profiles are linked yet.

## Products

No published products profiles are linked yet.

## Investors

- [The Column Group](/institutions/the-column-group)

## Sources

- No source links are available for this profile.